Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.

NCT03165019 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT03165019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03165019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.
Lead sponsor
University of Zurich
Phase
Observational
Overall status
Completed
Start date
May 24, 2017
Completion date
August 16, 2017
Enrollment
165 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high altitude pulmonary hypertension, sleep apnea